HS-10390

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-10390, covering 2024-10-09 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy [Phase 2]